← Eichor
Study identifier: NCT06425380 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

Condition: Hepatic Encephalopathy · Cirrhosis  ·  Sponsor: Mayo Clinic

PhaseNA
Planned participants11
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

This research is studying how a food product (resistant potato starch) which is a dietary supplement made from potato starch affects the gut bacteria of people with cirrhosis and hepatic encephalopathy. The researchers in this study want to understand how potato starch works in the subject's body and how the body will react to it. Along with taking the study product participants health-related information and stool will be collected for this research study.

This description comes directly from the study's public registry record.

Talk to the study team

Jenny Obst  ·  507-255-1337  ·  obst.jenny@mayo.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Mayo ClinicRochester, Minnesota, United StatesRecruiting
Mayo ClinicRochester, Minnesota, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06425380